| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.05 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.037 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |